Joe Wolk
Joe Wolk is the Chief Financial Officer of Johnson & Johnson, a leading global healthcare company. He has been instrumental in managing the financial aspects of the company, particularly during challenging times such as the recent rejection of a $10-billion talc settlement aimed at resolving thousands of lawsuits related to alleged cancer risks associated with J&J's talc products.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 5.00 | 0.04% | +0% | 38,005,238 | 16,662 | $1,700,000 | 745$ |
| Ireland | 1 | 6.00 | 0.04% | +0% | 5,030,000 | 2,080 | $5,100 | 2$ |
| Totals | 2 | 43,035,238 | 18,742 | $1,705,100 | 747$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
Joe Wolk, J&J’s chief financial officer, said the administration’s investigation into drug imports could actually be beneficial.
6
Canada:
J&J Chief Financial Officer Joe Wolk stated that they are reversing $7-billion in the reserve previously held for the bankruptcy plan.
5